The efficacy of rimegepant for the acute treatment of vestibular migraine
We first demonstrate rimegepant 75 mg is safe and well-tolerated, which contributes a rapid relief of the prominent symptoms of VM including vertigo, unsteadiness or dizziness, nausea or vomiting, photophobia or phonophobia, and headache. Although required further validation, our findings may provide novel viewpoint on the treatment of VM.
Authors
- Jingwei Pan (ORCID: https://orcid.org/0000-0002-7403-8744)
- Chuyi Huang
- Heling Chu
Institutions
- Renji Hospital (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1038/s41598-026-39902-9
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China